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The Expert Panel on Theory of Reference Values
(EPTRV) was created in 1970 by the Committee on
Standards (later changed to Scientific Committee and
then to Scientific Division) of the International Fed-
eration of Clinical Chemistry (IFCC). Its task was to
develop a nomenclature and recommend procedures
for the production of reference values and their treat-
ment, and presentation of observed values in relation
to reference data.
The first document in the above-mentioned series
describes the subject of reference values and defines
various terms. It should be consulted prior to the





3. Transfer of reference value data
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5. Appendix: Methods of quality control
6. References
1. Introduction
1.1. Aim of the document
Observed values may be compared with reference
values or with the reference distribution, reference
limits and reference interval derived from the refer-
ence values (l, 5).
The purpose of this document is to provide guidance
on the requirements necessary to ensure that the ref-
erence values are produced using accurate and precise
methods. Failure to employ methods that have known
and suitably low levels oHnaccuracy and imprecision
reduce clinical Utility of the values obtained.
1.2. Perspective
It is important to establish and maintain a realistic
awareness of the contribütion that analytical inaccu-
racy and imprecision may have on the production of
reference values. The biological variance is an impor-
tant factor to take into consideration when determin-
ing the allowable imprecision and inaccuracy (6—8).
Thus, every effort should be made to establish the
level of analytical inaccuracy and imprecision toler-
able for the intended uses of the reference values. For
example, the Aspen Conference defined in 1976 the
tolerable level of imprecision for measurements of
calcium and urea in serum to be quite different, 0.9
per cent and 6.2 per cent (CV), respectively (cited in
I.e. (6)).
This document assumes that adequate effort has been
made to reduce biological Variation in selecting sub-
jects (2) and collecting specimens (3).
1.3. Need for reliable methods
• \
The method, including the reagents and equipment
used, must be described in enough detail that ade-
quately-trained analysts will all proceed in the same
manner and obtain reproducible results. The assess-
ment of these methods should be made according to
Part 2 of the Recommendations of the IFCC's Expert
Panel on Nomenclature and Principles of Quality
Control (9).
1.4. Need for long-term stability of the ana-
lytical method
The development of reference values is a time^con-
suming and costly exercise. As a result, it is essential
that the values must have application över a lengthy
period. Furthermore, the true clinical Utility of the
values in diagnosis, comparative assessrnent and long-
term monitoring necessitates the employment of well
controlled analytical procedures.
1.5. Experimental design
In the production of reference values it is desirable to
keep analytical väriaiice of äppröximately the same
magnitude äs that obtained by good-quality routine
analysis. Therefore, it is strongly recommended that
the measurements for the production of reference
values be made under stncily controlled, but realistic
routine conditions, including the day-to-day impre-
cision.
1.6. Transferability
The complexity, cost and effort of establishing refer-
ence values are often minor compared to the problem
of obtaining a sufficient number of adequate speci-
mens for the production of the reference values. As a
result it is often necessary to transfer reference values
from one Institution to another. In this case there is
an essential need for laboratories involved to obtain-
comparable results. That can be achieved by assess-
ment of the accüracy and precision of the analytical
method in use thrpugh long-terin inter-laboratory
studies (10).
Comparability of results is also necessary for labor-
atories receiving specimens from a highly mobile pop-
ulation. It may be best achieved using similar aiialyt^·
ical procedures. Should they be different, it is impor-
" tant that they coüform to tölerable limits of inaccu-
racy and imprecision. · >
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2. Monitoring Procedures
2.1.
The theoretical principles underlying quality control
(QC) and the various forms QC can take are treated
in detail in the recommendation of the Expert Panel
on Nomenclature and Principles of Quality Control
in Clinical Chemistry (9).
There are numerous QC procedures which will mon-
itor the accuracy and precision of the analyses, and
ensure the transferability of the data. This section
provides elementary guidance in QC procedures for
this purpose. It is assumed that laboratories perform-
ing this work will have certain materials and facilities
available which will, probably, be in use routinely.
However, it is essential that the following conditions
are met:
The calibration material must be earefully de-
fined (9, 11), keeping in mind the presence of
non-specific components which may contribute
to the reading.
The basis for calculation, e. g., molar lineic ab-
sorbance (9, 11), must be earefully defined and
tested.
Suitable control specimens must be available
commercially or be prepared by the user. They
should have a matrix that has properties similar
to those of the specimens used for the produc-
tion of reference values (7 — 11). To ensure
proper monitoring of accuracy, precision and
reliability of a method, selected control mate-
rials should be validated (10).
The control pröcedure should be described in
detail. This description should also include de-
cision rules for outeofrcontrol situations aiid
actions tö perförm when an alarm occurs (12).
2.2. Recommendation for single laboratory
scheme
In most cases, a simple System involving control spec-
imens is recommended for this purpose because of its
general applicability (9). The recommended System
(13, 14) consists of intemal and external quality con-
trol procedures, see Scheme 1. (External quality con-
trol is also called external quality assessment.)
The procedures for the two separate kinds of internal
control, control of precision and control of accuracy,
are shown in Scheme 2.
Scheme l. Basic program for quality control
Internal quality control
Control of precision
— in every run of analyses, even if the run consists of only
one patient specimen
— with precision control specimen
Control of inaccuracy
— in at least every 4th run
— with accuracy control specimen
External quality control (or assessment)
Interlaboratory surveys
— at least three times a year for each types of quantity
— specimens shipped by the chief investigator
— evaluation on the basis on analytical results from independ-
ent reference laboratories
In accuracy control it is important that the whole
clinically relevant interval of measurement be moni-
tored.
In some cases control rules are needed that are more
sensitive to inaccuracy and imprecision than those
described in Scheines l and 2. For example, it is
important to detect small increases in inaccuracy and
imprecision of the analysis of the concentration of
calcium in serum because of the small biological var-
iance of this component. Westgard, Groth and co-
workers have developed control Systems that may
ensure that the analytical quality is within stated limits
(12, 15).
2.3. Recommendation for multiple labor-
atory scheme
If several laboratories are to participate in the pro-
duction of reference values, the eomparability of the
results from these laboratories must first be evaluated.
If comparability is inadequate, appropriate changes
must be made in the analytical system. Whenever
several laboratories are involved, there must be on-
going checks on comparability while reference values
are being produced.
Prior to analyzing the specimens from the reference
individuals the laboratories should assess the com-
parability of their analytical results by using the same
control material. Where stability of the component
permits, it is advisable also to check comparability by
exchanging native human specimens between labor-
atories. An effective model for conducting and eval-
uating such a long-term survey has been developed
and experience with the model has been reported (10).
If the data from the comparison study show that no
significant effect on the size of the reference interval
will be the result, then a multi-laboratory study can
proceed.
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Scheme 2: Recommended basic internal quality control
Control of precision Control of accuracy






A precision control specimen from a batch used for
äs long a time äs possible
Concentration at the decision limit
Control chart
One of a number of difterent accuracy control spec-
imens kept on band
Assigned välues at normal and pathological levels







Does not know concentration (known to control
Supervisor of the laboratory)
Goals Assessment of random Variation (random errors)
Detection of trends
Detection of systematic deviations (systematie errors)
Monitoring over the whole diagnostically relevant
interval
Detection of influence of other cömponents (matrix)
Elimination of intentional or unintentional misinter-
pretation of data by analyst
3. Transfer of Reference Value Data
The diversity of analytical procedures has complicated
the establishment of transferable reference välues.
Therefore, employment of the above mentioned QC
procedures with well operated and documented meth-
odology is a prerequisite for the transfer of reference
value data from one laboratory to another; so is also
the comparability of the populations involved. How-
ever, it is important to realize that the clinical envi-
ronment is dynamic, and that reference välues and
associated data may become invalid or inappropriate
over a period of time. To prevent the obsolescence of
reference value data it is-imperative to ensure the
following:
Monitor changes in method accuracy and pre-
cision.
Check relevance of reference value data to in-
dividuals and/or groups being assessed.
Store the original reference value data.
Update reference value Information when nec-
essary.
4. Comment
The Schemes l and 2 recommended in this docüment
provide guidance and do not constitute the only ef-
fective methods of controlling and monitoring ana-
lytical Variation.
5. Appendix: Methods of Quality Controls
A simple procedure for the control of accuracy and
precision is showri in Schemes l and 2.
5.1. Accuracy control
It is essential to detect changes in the calibration cürve
over time and to monitprjthe.specificity of the ana-
lytical method.
This requires a number of accuracy control specimens
at both normal and pathological levels of concentra-
tions of the type of quantity for which reference välues
are to be produced. These control specimens should
contain quite different kinds of matrix, arid should
also contain other cömponents that might disturb the
analysis. Accuracy and specificity are not monitored
adequately if the different coneentrations of the target
component are obtained by spiking the same matrix
or by adding different amounts of dilueht to the same
amount of the specimen during reconstruction.
5.2. Precision control
To ensure that the required precision is mäintained
and to detect trends, it is recommended that an acie-
quate nuimber of control specimerjs be included at
fixed or random positions in each analytical run (7,
8). Ideally precision control should be employed at
different levels of concentration. If only one precision
control is used the concentration should coineide with
the clinical discrimination
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